Company Overview and News
2018-10-15 zacks - 1
Kinder Morgan Inc (KMI - Free Report) is expected to post third-quarter 2018 results on Oct 17. In the last reported quarter, the company delivered positive earnings surprise of 10.5%. Moreover, the company has pulled off an average positive earnings surprise of 9.8% in the last four quarters. Let’s see how things are shaping up prior to the announcement.
COP KMI OXY KMR KMRFZ CVB EOG
Investors are always looking for stocks that are poised to beat at earnings season and Kinder Morgan, Inc. (KMI - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
KMI KMR KMRFZ CVB
Midstream sold off along with most things this week, but as a whole did slightly better than the broad stock market, outperforming for a second straight week. MLPs were the best-performing group in midstream, benefiting from their renewed obscurity more than a flight to safety. Just like when the S&P 500 is going up, the market seems pre-occupied with itself, rather than paying much attention to midstream and certainly not MLPs.
KEYUF GPRE COG AR NAP AM GNE NNA KMI WMB GPP GNE AMGP KMR PBA FGP CVB KMRFZ GEL
The broad markets saw a massive drop this past week but posted a small recovery to close out the week. This drop off could offer a nice buying opportunity as the third-quarter earnings reporting season gets underway. 24/7 Wall St. has put together a preview of some of the major companies posting their quarterly results this week.
PM NFLX PYPL BAC HON KMI MS KMR CVB HON BAC SLB SYF UAL HON.WI TRI SCL SLB KMRFZ
Petroleum still powers the world’s economies, and overall demand continues to climb. Over just the last six years, global oil demand per day has jumped by 10.14% according to the International Energy Agency (IEA).
KMI PAGP EPD KMR MPC PBA CVB KMRFZ BPL
2018-10-13 seekingalpha - 5
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
GLBS PERY PSX LCII ABT CRM SHPG CSCO MS AMC COF-P SMPL ISRG SYF DVMT IDA JNJ HON.WI MSFT HLUKF LEVL FTCH APHQF UTHR MTW ADS FB SCL NFLX AXP SKX SU BAC COF-D COF-C COF-F AAPL CCI ELAN HUBB CE SU EB SURF TRIP PVTL GSK EOG SIX JPM PATK SBUX CNTTF KMRFZ CNC CNK WMT NKE SHAK AMZN HON KMI TWTR HCSG GSK TRMB EAF KMR AA DXC CVB EBAY REGN SLB BAC DFS CRON STBA SC UAL GOOGL LTXB AHBIF PENN SCL SLB QCOM WFCNP XLNX PM PG PNK CPB PYPL VMW WGO TLRY USB GS MYL JEC SWI XYF WEED DXC.WI ECL ABT IBM CWH WFC HON BUD C TPR CMCSA THO COF BSVN LECO CGC SNY VLTHF V SCHW HP T MRK SNE DPZ
Will rising interest rates hurt pipeline company stocks? Ten-year treasury yields were recently at 3.25%, a seven-year high. The bond market is commanding the attention of equity investors once more. Energy infrastructure should be able to withstand rising rates because of strong fundamentals.
OKE.WI KMI AMGP OKE KMR KMRFZ CVB
Hurricane Michael made landfall at the Florida panhandle as a Category 4 hurricane Wednesday with 155 mph winds, quickly destroying demand for power, natural gas and refined oil products. Shut-in oil production rose modestly from Tuesday to over 700,000 b/d, but the storm has stayed east of much of the region's production, which means supply should be back online quickly.
PBEGF SOJA ALPPRN ALPPRQ GUL GPJ KMI GLFQP KMR CVB APRCP SO GAPWP ALPVN GPJA GPEPRA ALAWP GLFPO APRDN ALBMP APRDM APRDP APRDO KMRFZ GLFPN
2018-10-12 investorplace - 5
In any market — bull or bear — investors can always find turnaround stocks to buy. Companies are no more perfect than the humans that comprise them, after all. Mergers go south. Poor management can decimate morale. Sometimes, the world changes — and it takes a few years for a business to catch up.
LOW JCP CHKVP UAA CHKVZ TTS BHC SHLD NKE KMI VSI KMR CVB GE FTD CBS.WD CMG GPRO MAT CHK VZ CPV BATRA FTR LSXMB HD FIT BATRK CPB LSXMA FND BATRR CHKDH CHKDG VZA CHKDJ VRX CHKDP FTRPR GRMN AAPL BATRB CBS VIA CKRGZ GEC FWONB CBS.A QRTEA M FLWS FWONA CHKWZ UA HAS CHK.WI KHC FWONK GNE LSXMK KMRFZ DHR
The bulls did their best to bring the market back from the brink, but the follow-through on Monday’s modest strength ultimately failed. The S&P 500 ended the day down 0.14%, resting right on a pivotal support line.
PCG ZNGA F KMI FAST KMR KMRFZ CVB SNAP
HOUSTON (Reuters) - Hurricane Michael on Wednesday cut 42 percent of U.S. Gulf of Mexico daily crude oil production and nearly a third of natural gas output, the largest reductions in a year, after companies evacuated staff and shut-in platforms as a precaution.
SOJA SO APC BLT XOM BHPBF KMI BHP CVX BBL BHP KMR BHPLF CVB AEUA KMRFZ
This is the sixth month I have officially tracked dividend income (in an article) for John's Traditional and Roth IRA Accounts. His dividend income totaled $1,166.72.
POR CAT HTA RF LTC OPRF WMT KMI OMI WELL CBRL KMR CVB ABBV BBT DUKH GD NYSE MAIN KMB CLDT WPC ABBV OXY BA PK SCG HRNNF TD VLY CONE BOE MSCA SCU TD VTR RDS.A H TNTTF O PACW DUK MSCA.CL SCHW PEP CVX KMRFZ
Kinder Morgan (NYSE:KMI) is well-positioned to benefit from the long-term natural gas consumption megatrend. Thanks to new growth projects in the Permian Basin and elsewhere, the company will generate rising cash flows, and higher oil prices will be beneficial for its CO2 segment.
KMI KMR KMRFZ CVB
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to KMI / Kinder Morgan, Inc. on message board site Silicon Investor.
|Kinder Morgan Inc-(KMI)||Kinder Morgan Inc-(KMI)||Kinder Morgan Inc-(KMI)||KMI- a fallen high dividend yielder - for how long?||KMI- a fallen high dividend yielder - for how long?||KMI- a fallen high dividend yielder - for how long?|
as of ET